Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SSRI efficacy-finding the right dose.

Charles F Caley1, Judith C Kando

  • 1University of Connecticut and Burlingame Research Center, Hartford 06106-3392, USA.

Journal of Psychiatric Practice
|June 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychiatric learning experiences in PGY1 pharmacy residency training: A 5-year analysis.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2024
Same author

Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working Group.

Innovations in clinical neuroscience·2024
Same author

Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day.

Journal of child and adolescent psychopharmacology·2023
Same author

Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of Amphetamine Extended-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder.

The Journal of clinical psychiatry·2022
Same author

Addressing the Conflict Between Promoting Wellness, Perpetuating Mental Illness Stigma and Making Psychiatric Pharmacy Education Less Intense.

American journal of pharmaceutical education·2021
Same author

Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD.

Drug design, development and therapy·2021

Selective serotonin reuptake inhibitors (SSRIs) offer effective depression treatment with fewer side effects and simpler dosing than TCAs. Many patients respond well to the initial SSRI dose, avoiding lengthy titration periods.

Area of Science:

  • Pharmacology
  • Psychiatry
  • Clinical Therapeutics

Background:

  • Selective serotonin reuptuptake inhibitors (SSRIs) are widely used antidepressants.
  • Compared to tricyclic antidepressants (TCAs), SSRIs offer improved safety, reduced side effects, and simpler dosing.
  • TCAs often require gradual dose titration, which can lead to treatment discontinuation.

Purpose of the Study:

  • To review the recommended dosage ranges for five commonly prescribed SSRIs.
  • To highlight the advantages of SSRIs, particularly their suitability for initial optimal therapeutic dosing in major depression treatment.

Main Methods:

  • Literature review of SSRI dosing guidelines.
  • Comparative analysis of SSRI and TCA dosing strategies.

Related Experiment Videos

Main Results:

  • SSRIs generally do not require dose titration, unlike TCAs.
  • Many patients find the initial dose of SSRIs effective, simplifying treatment initiation.
  • Recommended dose ranges for citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline are considered.

Conclusions:

  • SSRI dosing simplifies treatment initiation and adherence for major depression.
  • The absence of dose titration for SSRIs can improve patient outcomes and reduce healthcare burdens.